A Study to Determine the Metabolism and Elimination of Carbon-14 Labeled Eribulin Acetate (14C-Eribulin) in Patients With Advanced Solid Tumors
Clinical trial NCT00908908 · COMPLETED
Trial details
- NCT number
- NCT00908908
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2011-05-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.